Ticker
SGMOCompany Name
SANGAMO THERAPEUTICS INCSector
HealthcareIndustry
BiotechnologyExchange
NASDAQDate | Cash and Equivalents | Cash Ratio | Current Liabilities |
---|---|---|---|
6/30/2025 | $ 39.84M | 0.84 | $ 47.66M |
3/31/2025 | $ 26.68M | 0.54 | $ 49.56M |
12/31/2024 | $ 43.42M | 0.95 | $ 45.8M |
9/30/2024 | $ 40.7M | 0.94 | $ 43.16M |
6/30/2024 | $ 27.79M | 0.71 | $ 39.01M |
3/31/2024 | $ 55.33M | 1.38 | $ 40.24M |
12/31/2023 | $ 46.7M | 0.98 | $ 47.73M |
9/30/2023 | $ 58.01M | 1.2 | $ 48.48M |
6/30/2023 | $ 68.33M | 1.27 | $ 53.79M |
3/31/2023 | $ 79.74M | 1.38 | $ 57.84M |
We picked the following companies as peers based on multiple factors, including sector, industry, market capitalization and revenue
CashnEq / LiabilitesC
(=) Cash Ratio
Cash Ratio for SANGAMO THERAPEUTICS INC is calculated as follows: CashnEq [ $ 260.89M ] / LiabilitesC [ $ 123.56M ]
(=) Cash Ratio [ 2.11 ]
Minimum
Mar 31, 2025
Maximum
Sep 30, 2020
Average
Median
filtered constituents | 3.13K |
---|---|
min | 0 |
max | 2.69 |
average | 0.62 |
median | 0.39 |
std | 0.63 |